Sam Colin

Senior Managing Director Portfolio Manager
Sam Colin

Sam Colin, MD, joined First Manhattan in 1994 as a Research Analyst focusing on the pharmaceutical and biotechnology industries. In addition to managing individual accounts, Sam combines his medical training and investment research experience to manage the First Health and First BioMed suite of private investment vehicles, which focus on investing in the healthcare industry. He also serves on First Manhattan’s Research Steering Committee.

Sam holds an MD from the Yale University School of Medicine and a BS from Brown University.